$SWIM

Latham Group (SWIM) Q2 2026 Earnings Call Transcript

Latham Group, Inc. (SWIM) reported Q2 2026 net sales of $197.5 million, up 14.4% year over year, driven by 10.3% organic growth and the Freedom Pools acquisition. Adjusted EBITDA rose to $44.6 million. Net income fell to $12.8 million due to a $5.0 million FX impact. Full-year guidance: net sales $600 million to $620 million, adjusted EBITDA $110 million to $120 million.

Original reporting
Published Aug 12, 2026, 2:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 3:09 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Latham Group (SWIM) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$SWIMBullishMed
01

Why it matters

The key tradable items are the raised full-year net sales and adjusted EBITDA guidance, alongside disclosed margin pressure drivers (ramp-up costs) and freight surcharge timing that may drive estimate revisions.

02

Market read

Guidance increase is the primary catalyst, while margin and logistics commentary adds uncertainty around the path to those targets.

03

What to watch

The article notes $2.8M in unabsorbed ramp-up costs expected to be recovered in H2, so traders should watch whether inventory restocking and production absorption actually track management’s recovery timeline.

Relevance 8/10Novelty 8/10Timing: ahead of next earnings revisions, post-call guidance update

Background

This is a Q2 2026 earnings call transcript for Latham Group, covering results, guidance, and operational drivers including the Freedom Pools acquisition and fiberglass demand.

Company-level read

Ticker impact

$SWIMBullishMedium confidence
Context

Latham Group reported Q2 net sales of $197.5M and raised full-year guidance to $600M-$620M net sales and $110M-$120M adjusted EBITDA.

Expected impact

Likely positive bias for the stock on guidance increase, tempered by concerns about gross margin pressure and unabsorbed ramp-up costs.

Evidence & confidence

The article discloses specific Q2 results and an increased full-year guidance range, but also highlights gross margin decline (ramp-up costs) and freight surcharge lag, which can affect near-term estimates and revisions.

Market effects

Signals continued demand strength in fiberglass in-ground pools and potential competitive share gains, which can influence sentiment across pool materials and installation supply chains.

Highlights expansion focus and double-digit growth in Florida, Texas, Arizona, and California, reinforcing regional demand expectations for Sunbelt home improvement.

Freight and Middle East conflict transportation costs are cited as a factor, which can marginally affect input logistics assumptions for manufacturers with similar supply chains.

Counterpoint

Raised guidance may still mask near-term margin risk, given gross margin contraction from incremental ramp-up costs and inability to fully offset freight inflation beyond $100 oil/diesel assumptions.

Key entities

  • Latham Group, Inc.

    Reports Q2 results and increased full-year guidance; discusses fiberglass demand, Sand States expansion, and margin/ramp-up and freight dynamics.

  • Sean Gadd

    CEO who commented on readiness/planning issues behind unabsorbed ramp-up costs and growth initiatives.

  • Oliver Gloe

    CFO who discussed freight surcharge lag and transportation cost offset limitations.

Related articles

MedAI 8/10

Latham & Watkins Advises on BlossomHill Therapeutics’ Upsized US$150 Million IPO

BlossomHill Therapeutics priced an upsized US$150 million IPO, selling 9,375,000 shares at US$16.00 each, with gross proceeds expected to be US$150.0 million before fees. The underwriters received a 30-day option to buy up to 1,406,250 additional shares. Latham & Watkins advised the underwriters, with FDA and other specialty support.

$LOGCMedAI 8/10

Latham Represents Blackstone Credit & Insurance in Financing for ContextLogic’s Acquisition of gChem for US$850 Million

ContextLogic Holdings (OTCQB: LOGC) said it will acquire gChem, the holding company of Gaylord Chemical and subsidiaries, from funds managed by EagleTree Capital and co-investors. The deal values gChem at an enterprise value of US$850 million. Financing will come from Blackstone Credit & Insurance, including a US$250 million term loan and US$25 million revolver, per the company.